Quince Therapeutics (QNCX) Revenue & Revenue Breakdown


OverviewForecastFinancialsChart

Quince Therapeutics Revenue Highlights


00

Quince Therapeutics Revenue by Period


Quince Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

Quince Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Quince Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$168.00K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$36.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

Quince Therapeutics generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Quince Therapeutics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
CAMPCAMP4 Therapeutics$186.23M$795.00K
DTILPrecision BioSciences$68.70M$13.00K
MGXMetagenomi$44.76M$8.66M
CNTBConnect Biopharma$26.03M$48.00K
ADVMAdverum Bio$1.00M-
ATYRaTyr Pharma$353.00K$190.00K
GUTSFractyl Health$120.00K-
IFRXInflaRx$61.80K$36.25K
ALXOALX Oncology--
QNCXQuince Therapeutics--
KLRSKalaris Therapeutics--

QNCX Revenue FAQ


What is Quince Therapeutics’s yearly revenue?

Quince Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. QNCX's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Quince Therapeutics’s quarterly revenue?

Quince Therapeutics's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). QNCX's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Quince Therapeutics’s revenue growth rate?

Quince Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.